Q4 2024 Management View Walter Klemp, Chairman and CEO, announced significant progress on the MIRACLE Phase 3 pivotal trial for Annamycin, targeting second-line treatment of relapsed and refractory ...

Last fall, when initial data from the Centers for Disease Control and Prevention showed a surprising drop in drug overdose deaths, the universal response was relief. We were finally getting something ...

About 270 000 people were in 2023 diagnosed with TB. Of those, 56 000 lives were lost, which translates to 153 people every day.

The innovations from the NGEI cluster span critical sectors and represent significant opportunities for investment and ...